FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)

View source ↗

Summary

FDA approved a supplemental application for Venlafaxine Hydrochloride (extended-release) submitted by Chartwell RX, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Anxiety Disorder
• Major Depressive Disorder
• Panic Disorder
• Social Anxiety Disorder

Drugs mentioned

• Venlafaxine hydrochloride (extended-release) (Venlafaxine hydrochloride, extended release)

Snippet

SUPPL AP for VENLAFAXINE HYDROCHLORIDE (VENLAFAXINE HYDROCHLORIDE)